Total Payments
$1,655
2024 Payments
$235.62
Companies
23
Transactions
75
Medicare Patients
887
Medicare Billing
$108,426
Payment Breakdown by Category
Food & Beverage$1,655 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,655 | 75 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $263.85 | 8 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $246.10 | 11 | $0 (2024) |
| ABBVIE INC. | $145.92 | 3 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $140.04 | 8 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $132.74 | 3 | $0 (2024) |
| PFIZER INC. | $125.05 | 7 | $0 (2024) |
| Depomed, Inc. | $90.16 | 6 | $0 (2017) |
| Allergan Inc. | $87.16 | 6 | $0 (2019) |
| MITSUBISHI TANABE PHARMA AMERICA, INC. | $49.88 | 2 | $0 (2024) |
| ASSERTIO THERAPEUTICS, Inc. | $45.28 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $235.62 | 9 | MITSUBISHI TANABE PHARMA AMERICA, INC. ($49.88) |
| 2023 | $342.65 | 9 | ABBVIE INC. ($129.18) |
| 2022 | $106.39 | 6 | Collegium Pharmaceutical, Inc. ($51.84) |
| 2021 | $36.00 | 2 | Amgen Inc. ($24.46) |
| 2020 | $56.17 | 3 | SANOFI-AVENTIS U.S. LLC ($21.82) |
| 2019 | $260.57 | 14 | Amgen Inc. ($85.28) |
| 2018 | $309.97 | 13 | Amgen Inc. ($120.00) |
| 2017 | $307.23 | 19 | Depomed, Inc. ($90.16) |
All Payment Transactions
75 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.48 | General |
| Category: PAIN | ||||||
| 08/06/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: PAIN | ||||||
| 07/17/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: Neurology | ||||||
| 07/17/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Neuromodulation | ||||||
| 04/30/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $47.64 | General |
| Category: Musculoskeletal | ||||||
| 04/02/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), EXSERVAN, RADICAVA ORS | Food and Beverage | In-kind items and services | $27.28 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 03/12/2024 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: Neurology | ||||||
| 01/02/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $20.94 | General |
| Category: Opioid Analgesic | ||||||
| 12/12/2023 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2023 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.08 | General |
| Category: PAIN | ||||||
| 10/04/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $45.05 | General |
| Category: Musculoskeletal | ||||||
| 08/01/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: Neurology | ||||||
| 07/12/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $17.50 | General |
| Category: Opioid Analgesic | ||||||
| 06/07/2023 | Bioventus LLC | Durolane (Device) | Food and Beverage | In-kind items and services | $32.12 | General |
| Category: Orthopedics/Orthopedic Surgery | ||||||
| 06/01/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $110.35 | General |
| Category: NEUROSCIENCE | ||||||
| 04/04/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $40.05 | General |
| Category: Musculoskeletal | ||||||
| 03/15/2023 | Ipsen Biopharmaceuticals, Inc | Dysport (Drug) | Food and Beverage | In-kind items and services | $31.34 | General |
| Category: Neurology | ||||||
| 12/06/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.71 | General |
| Category: Opioid Analgesic | ||||||
| 11/22/2022 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Neuroscience | ||||||
| 09/07/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: HYPERHYDROSIS | ||||||
| 08/08/2022 | Ipsen Biopharmaceuticals, Inc | DYSPORT (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Neurology | ||||||
| 07/13/2022 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $18.21 | General |
| Category: Opioid Analgesic | ||||||
| 05/04/2022 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $16.92 | General |
| Category: Opioid Analgesic | ||||||
| 11/02/2021 | Amgen Inc. | Aimovig (Biological) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 210 | 310 | $131,631 | $25,614 |
| 2022 | 7 | 252 | 349 | $145,985 | $30,865 |
| 2021 | 5 | 216 | 337 | $124,869 | $28,547 |
| 2020 | 5 | 209 | 317 | $119,628 | $23,400 |
Total Patients
887
Total Services
1,313
Medicare Billing
$108,426
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 126 | $51,282 | $10,497 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 32 | 45 | $24,570 | $5,140 | 20.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $17,864 | $3,152 | 17.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 39 | 55 | $15,290 | $3,132 | 20.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 30 | 40 | $14,240 | $2,343 | 16.5% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 15 | 15 | $8,385 | $1,349 | 16.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 85 | 154 | $58,904 | $12,977 | 22.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 42 | 50 | $25,750 | $5,844 | 22.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 32 | 32 | $18,536 | $3,318 | 17.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 48 | $12,644 | $3,001 | 23.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 27 | 37 | $12,500 | $2,483 | 19.9% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2022 | 17 | 17 | $11,808 | $2,292 | 19.4% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2022 | 11 | 11 | $5,843 | $950.16 | 16.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 77 | 141 | $52,170 | $12,846 | 24.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 87 | $22,011 | $4,882 | 22.2% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 44 | 44 | $24,640 | $4,579 | 18.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 23 | 29 | $14,384 | $3,502 | 24.3% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 23 | 36 | $11,664 | $2,738 | 23.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 78 | 147 | $54,390 | $10,220 | 18.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 42 | 42 | $23,520 | $4,699 | 20.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 41 | 66 | $16,814 | $3,320 | 19.7% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 26 | 28 | $13,888 | $2,793 | 20.1% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2020 | 22 | 34 | $11,016 | $2,368 | 21.5% |
About Dr. Victor Lin, M.D
Dr. Victor Lin, M.D is a Specialist healthcare provider based in Eugene, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487613261.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Victor Lin, M.D has received a total of $1,655 in payments from pharmaceutical and medical device companies, with $235.62 received in 2024. These payments were reported across 75 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($1,655).
As a Medicare-enrolled provider, Lin has provided services to 887 Medicare beneficiaries, totaling 1,313 services with total Medicare billing of $108,426. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Eugene, OR
- Active Since 03/21/2006
- Last Updated 01/16/2018
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1487613261
Products in Payments
- Aimovig (Biological) $263.85
- Dysport (Drug) $136.52
- Xeomin (Biological) $132.74
- QULIPTA (Drug) $110.35
- XTAMPZA (Drug) $109.17
- Nucynta (Drug) $90.16
- Dysport 300 U-1 (Drug) $88.27
- BOTOX (Biological) $80.16
- LYRICA (Drug) $63.93
- NURTEC ODT (Drug) $61.12
- RADICAVA (Drug) $49.88
- Gralise (Drug) $45.28
- OSMOLEX ER (Drug) $37.07
- VYVGART HYTRULO (Drug) $35.08
- SPINRAZA (Biological) $34.55
- Durolane (Device) $32.12
- ARYMO ER (Drug) $26.43
- BOTOX THERAPEUTIC (Biological) $23.74
- SYNVISC-ONE (Device) $21.82
- DYSPORT (Drug) $21.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Eugene
Dr. Mark Jewell, M.d, M.D
Specialist — Payments: $785,393
Specialist $785,393
Dr. Kiumars Movassaghi, Medical Doctor, MEDICAL DOCTOR
Specialist — Payments: $473,647
Specialist $473,647
Hillary Jewell
Specialist — Payments: $21,527
Specialist $21,527
Dr. Lee Daniel, M.d, M.D
Specialist — Payments: $16,681
Specialist $16,681
Dr. Nicholas Telew, M.d, M.D
Specialist — Payments: $4,176
Specialist $4,176
Dr. James Knackstedt, M. D, M. D
Specialist — Payments: $1,935
Specialist $1,935